Hypoxic preconditioning: role of transcription factor HIF-1α;Préconditionnement hypoxique : rôle du facteur de transcription HIF-1α

Annales de Cardiologie et d'Angeiologie

Volumn 55, Issue 2, 2006, Pages 70-73

  Belaidi E ^a   Beguin P C ^a   Ribuot, C ^a   Godin Ribuot, D ^a  

^a University Grenoble Alpes   (France)

Author keywords

Delayed myocardial preconditioning; HIF 1 ; Hypoxia; Prolyl 4 hydroxylases

Indexed keywords

HYPOXIA INDUCIBLE FACTOR 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; HIF1A PROTEIN, HUMAN;

ARTICLE; CARDIOVASCULAR DISEASE; HEART PROTECTION; HUMAN; HYPOXIA; ISCHEMIC PRECONDITIONING; CELL HYPOXIA; HEART INFARCTION PREVENTION; METHODOLOGY; PHYSIOLOGY; REVIEW; TIME;

CELL HYPOXIA; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; ISCHEMIC PRECONDITIONING, MYOCARDIAL; TIME FACTORS;

EID: 33646469245     PISSN: 00033928     EISSN: 17683181     Source Type: Journal    
DOI: 10.1016/j.ancard.2006.02.011     Document Type: Article

References (26)

1. Bolli R. The early and late phases of preconditioning against myocardial stunning and the essential role of oxyradicals in the late phase: an overview. Basic Res. Cardiol. 91 (1996) 57-63
2. Bolli R. The late phase of preconditioning. Circ. Res. 87 (2000) 972-983
3. Stein A.B., Tang X.L., Guo Y., Xuan Y.T., Dawn B., and Bolli R. Delayed adaptation of the heart to stress: late preconditioning. Stroke 35 (2004) 2676-2679
4. Yellon D.M., and Downey J.M. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol. Rev. 83 (2003) 1113-1151
5. Xuan Y.T., Tang X.L., Banerjee S., Takano H., Li R.C., Han H., et al. Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ. Res. 84 (1999) 1095-1109
6. Zhong C., Zhou Y., and Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology 100 (2004) 540-546
7. Li G., Labruto F., Sirsjo A., Chen F., Vaage J., and Valen G. Myocardial protection by remote preconditioning: the role of nuclear factor kappa-B p105 and inducible nitric oxide synthase. Eur. J. Cardiothorac. Surg. 26 (2004) 968-973
8. Beguin P.C., Joyeux-Faure M., Godin-Ribuot D., Levy P., and Ribuot C. Acute intermittent hypoxia improves rat myocardium tolerance to ischemia. J. Appl. Physiol. 99 (2005) 1064-1069
9. Cai Z., Manalo D.J., Wei G., Rodriguez E.R., Fox-Talbot K., Lu H., et al. Hearts from rodents exposed to intermittent hypoxia or erythropoietin are protected against ischemia-reperfusion injury. Circulation 108 (2003) 79-85
10. Semenza G.L. HIF-1: mediator of physiological and pathophysiological responses to hypoxia. J. Appl. Physiol. 88 (2000) 1474-1480
11. Huang L.E., Gu J., Schau M., and Bunn H.F. Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitinproteasome pathway. Proc. Natl. Acad. Sci. USA 95 (1998) 7987-7992
12. 2 sensing. Science 292 (2001) 464-468
13. Zermati Y., Fakhouri F., Delarue R., Ribeil J.A., Knebelmann B., and Hermine O. Régulation de l'érythropoïèse: applications physiopathologiques en néphrologie (2003), Flammarion Médecines-Sciences, Paris
14. Wang G.L., and Semenza G.L. Desferrioxamine induces erythropoietin gene expression and hypoxia-inducible factor 1 DNA-binding activity: implications for models of hypoxia signal transduction. Blood 82 (1993) 3610-3615
15. Cioffi C.L., Liu X.Q., Kosinski P.A., Garay M., and Bowen B.R. Differential regulation of HIF-1 alpha prolyl-4-hydroxylase genes by hypoxia in human cardiovascular cells. Biochem. Biophys. Res. Commun. 303 (2003) 947-953
16. Natarajan R., Salloum F.N., Fisher B.J., Kukreja R.C., and Fowler III A.A. Hypoxia inducible factor-1 activation by prolyl 4-hydroxylase-2 gene silencing attenuates myocardial ischemia reperfusion injury. Circ. Res. 98 (2006) 133-140
17. Chun Y.S., Choi E., Kim G.T., Choi H., Kim C.H., Lee M.J., et al. Cadmium blocks hypoxia-inducible factor (HIF)-1-mediated response to hypoxia by stimulating the proteasome-dependent degradation of HIF-1alpha. Eur. J. Biochem. 267 (2000) 4198-4204
18. Bergeron M., Gidday J.M., Yu A.Y., Semenza G.L., Ferriero D.M., and Sharp F.R. Role of hypoxia-inducible factor-1 in hypoxia-induced ischemic tolerance in neonatal rat brain. Ann. Neurol. 48 (2000) 285-296
19. Brahimi-Horn C., Mazure N., and Pouyssegur J. Signalling via the hypoxiainducible factor-1alpha requires multiple posttranslational modifications. Cell Signal 17 (2005) 1-9
20. Bernaudin M., Nedelec A.S., Divoux D., MacKenzie E.T., Petit E., and Schumann-Bard P. Normobaric hypoxia induces tolerance to focal permanent cerebral ischemia in association with an increased expression of hypoxia-inducible factor-1 and its target genes, erythropoietin and VEGF, in the adult mouse brain. J. Cereb. Blood Flow Metab. 22 (2002) 393-403
21. Semenza G.L., Roth P.H., Fang H.M., and Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J. Biol. Chem. 269 (1994) 23757-23763
22. Coulet F., Nadaud S., Agrapart M., and Soubrier F. Identification of hypoxiaresponse element in the human endothelial nitric-oxide synthase gene promoter. J. Biol. Chem. 278 (2003) 46230-46240
23. Jung F., Palmer L.A., Zhou N., and Johns R.A. Hypoxic regulation of inducible nitric oxide synthase via hypoxia inducible factor-1 in cardiac myocytes. Circ. Res. 86 (2000) 319-325
24. Xi L., Tekin D., Gursoy E., Salloum F., Levasseur J.E., and Kukreja R.C. Evidence that NOS2 acts as a trigger and mediator of late preconditioning induced by acute systemic hypoxia. Am. J. Physiol. Heart Circ. Physiol. 283 (2002) H5-H12
25. Xi L., Taher M., Yin C., Salloum F., and Kukreja R.C. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am. J. Physiol. Heart Circ. Physiol. 287 (2004) H2369-H2375
26. Dendorfer A., Heidbreder M., Hellwig-Burgel T., Johren O., Qadri F., and Dominiak P. Deferoxamine induces prolonged cardiac preconditioning via accumulation of oxygen radicals. Free Radic. Biol. Med. 38 (2005) 117-124